The phosphoproteome of ovarian carcinoma delineates signaling signatures and potentially druggable targets across histotype stages.
- DOI
- 10.1038/s41698-026-01659-9
- Published
- 2026 Aug 14
- Container
- NPJ precision oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41698-026-01659-9,
title = {The phosphoproteome of ovarian carcinoma delineates signaling signatures and potentially druggable targets across histotype stages.},
author = {Werner L and Esmaeili P and Ittner E and Swenson H and Kovács A and Mateoiu C and Dahm-Kähler P and Karlsson P and Parris T and Levander F and Helou K},
year = {2026},
journal = {NPJ precision oncology},
doi = {10.1038/s41698-026-01659-9},
url = {https://doi.org/10.1038/s41698-026-01659-9}
}RIS
TY - JOUR TI - The phosphoproteome of ovarian carcinoma delineates signaling signatures and potentially druggable targets across histotype stages. AU - Werner L AU - Esmaeili P AU - Ittner E AU - Swenson H AU - Kovács A AU - Mateoiu C AU - Dahm-Kähler P AU - Karlsson P AU - Parris T AU - Levander F AU - Helou K PY - 2026 JO - NPJ precision oncology DO - 10.1038/s41698-026-01659-9 UR - https://doi.org/10.1038/s41698-026-01659-9 ER -
APA
L, W., P, E., E, I., H, S., A, K., C, M., P, D., P, K., T, P., F, L., & K, H. (2026). The phosphoproteome of ovarian carcinoma delineates signaling signatures and potentially druggable targets across histotype stages.. NPJ precision oncology. https://doi.org/10.1038/s41698-026-01659-9
Source records
- pubmed · retrieved 2026-09-26T03:34:20.542Z
- europe-pmc · retrieved 2026-09-26T03:34:20.559Z
- doaj · retrieved 2026-09-26T03:34:20.529Z